SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-003567
Filing Date
2024-03-19
Accepted
2024-03-19 16:02:50
Documents
90
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crvs-20231231x10k.htm   iXBRL 10-K 2515664
2 EX-21.1 crvs-20231231xex21d1.htm EX-21.1 6206
3 EX-23.1 crvs-20231231xex23d1.htm EX-23.1 1991
4 EX-31.1 crvs-20231231xex31d1.htm EX-31.1 14097
5 EX-31.2 crvs-20231231xex31d2.htm EX-31.2 14496
6 EX-32.1 crvs-20231231xex32d1.htm EX-32.1 7393
7 EX-97.1 crvs-20231231xex97d1.htm EX-97.1 67828
8 GRAPHIC crvs-20231231x10k007.jpg GRAPHIC 84890
9 GRAPHIC crvs-20231231x10k008.jpg GRAPHIC 79494
10 GRAPHIC crvs-20231231x10k009.jpg GRAPHIC 82006
11 GRAPHIC crvs-20231231x10k010.jpg GRAPHIC 79296
12 GRAPHIC crvs-20231231x10k011.jpg GRAPHIC 96681
13 GRAPHIC crvs-20231231x10k012.jpg GRAPHIC 118405
  Complete submission text file 0001558370-24-003567.txt   10676206

Data Files

Seq Description Document Type Size
14 EX-101.SCH crvs-20231231.xsd EX-101.SCH 52089
15 EX-101.CAL crvs-20231231_cal.xml EX-101.CAL 58250
16 EX-101.DEF crvs-20231231_def.xml EX-101.DEF 184668
17 EX-101.LAB crvs-20231231_lab.xml EX-101.LAB 512831
18 EX-101.PRE crvs-20231231_pre.xml EX-101.PRE 370000
94 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20231231x10k_htm.xml XML 1590191
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 24762983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)